Eisai expects Alzheimer's drug to rake in revenue of $66.5 million by March
© Reuters. The logo of Eisai Co Ltd is displayed at the company headquarters in Tokyo, Japan, March 8, 2018. REUTERS/Issei Kato/File Photo
The company said the launch of Leqembi in the United States was progressing as planned and that 10,000 patients were expected to be on the drug by the end of March 2024.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Daylight Saving impacting those affected by Alzheimer'sAs the sun sets, problems arise - especially for those affected by Alzheimer's disease. This is largely because a change in schedule can cause confusion.
Read more »
Grandmother Suffering From Alzheimer’s Still Able To Remember All Grandchildren’s FlawsLINCOLN, NE—Finding promise in her ability to recognize her eldest grandchild as the one who failed to make the soccer team in eighth grade, family sources confirmed Monday that 87-year-old grandmother Serena Jackson was suffering from Alzheimer’s disease but still able to remember all of her grandchildren’s flaws.
Read more »
Eli Lilly chief scientific officer ‘extremely optimistic’ that major new Alzheimer’s breakthrough is comingIn this interview, Dr. Daniel Skovronsky tells MarketWatch what the market is missing about Lilly–and what might be the GLP-1 drugs of the future–as he takes a spot on the MarketWatch 50 list of the most influential people in markets.
Read more »
Endless March: Princeton unveils new X-factor in season-opening win over RutgersBalance of new blood, savvy veterans powers Princeton past Rutgers in Trenton
Read more »
Scientific American, Volume XXIV., No. 12, March 18, 1871 by VariousScientific American, Volume XXIV., No. 12, March 18, 1871 by Various is part of the HackerNoon Books Series. Read this book online for free on HackerNoon!
Read more »